Board of Directors

Last Updated on Saturday, September 18, 2010

Katie Rielly-Gauvin, Board Chair & Treasurer brings more than 20 years of a broad range of business experiences in the pharmaceutical industry.  Ms. Rielly-Gauvin is currently Vice President of Global Commercial Development at AbbVie, a global biopharmaceutical company, where she is responsible for developing the strategic marketing direction of key compounds in AbbVie's pipeline across key Therapeutic areas in Immunology, Oncology, Neuroscience and Renal Care.  Prior to joining AbbVie, Ms. Rielly-Gauvin was at Johnson & Johnson where her last role was Vice President, Redscript Ventures, a Johnson & Johnson business accelerator created purposely for shaping new, venture stage business investments. Prior to this role, Ms. Rielly-Gauvin was Vice President of Sales & Marketing for the Janssen Commercial CNS organization, where she was responsible for a $3.0B product portfolio.  Ms. Rielly-Gauvin began her career at Johnson & Johnson family of companies in 1993, where she worked as Manager of Infectious Disease Research at Ortho-McNeil and held positions of increasing responsibility in Medical Affairs and the Commercial organizations.  She began her career with Bristol-Myers Squibb as a Research Scientist in clinical drug development. Ms. Rielly-Gauvin holds a Bachelor of Science degree in Chemistry from Simmons College and an MBA in Economics from Rutgers University.  She is an outside board member of the Family Guidance Center and resides in the Northern suburbs of Chicago with her husband and two children. Ms. Rielly-Gauvin has served on the Preeclampsia Foundation board since 2011.

Beth Frazer, JD, Vice Chair, received a Juris Doctrate from the University of Louisville Brandeis School of Law.  She practiced as a civil litigator, representing clients both in and out of court on a variety of matters including employment disputes and civil rights claims.  Ms. Frazer began her involvement with the Preeclampsia Foundation in 2008 after experiencing HELLP Syndrome when 20 weeks pregnant, which resulted in the death of her twins.  She and her husband, Bryan, live in Nashville, Tenn. with their son and daughter, and currently serve as co-coordinators of the Nashville Promise Walk for Preeclampsia.  Ms. Frazer has served on the Preeclampsia Foundation board since 2013.

Jerri Anne Johnson, Secretary, recently retired from Abbott Vascular with more than 35 years of education, pharmaceutical marketing and research experience. Her most recent project connected her to the Preeclampsia Foundation as she executed a national pilot to bring obstetricians, gynecologists and cardiologists together to screen women for heart disease and refer those at high risk. As Director of the Abbott Vascular Women's Heart Health Initiative, she traveled around the world to deliver education about heart disease in women and the connection between pregnancy complications and subsequent cardiovascular disease risk. She holds both undergraduate and master's degrees in Elementary Education from Millersville University. After teaching for 10 years, she joined Abbott and worked in positions of increasing responsibility including sales management, research and development, and marketing. On a personal level, her daughter, Lauren, experienced preeclampsia in her first pregnancy and a severe hypertensive event in her second pregnancy. She is very active in her university alumni association having recently served as president of the board of directors. She resides in Lancaster, Penn., with her husband, Jim, and golden-doodle, Coco, and is the mother of three, stepmother of 4, and Mimi to 2, soon to be 3 beautiful grandchildren. She joined the Foundation’s board in 2014.

Kathy Maguire, holds a Master's Degree in early childhood leadership and advocacy, with 20 years' experience in early childhood education. Most recently she worked as a Program Associate and Consultant to child care centers and elementary schools with an emphasis on continuous quality improvement and accreditation attainment. Ms. Maguire began volunteering with the Preeclampsia Foundation in January 2006 after experiencing preeclampsia, which resulted in her daughter's premature birth at 29 weeks. She served as the Director of Volunteer Development, National Walk-a-thon chair, and was honored as the 2007 Preeclampsia Foundation Volunteer of the Year.  Currently she is a stay-at-home mom and lives with her husband and daughter in Indiana. Ms. Maguire has served on the Preeclampsia Foundation board since 2011.

Matthew Cooper, PhD, MBA, is currently the CEO and Founder of Carmenta Bioscience, a company developing diagnostic tests for preeclampsia spun out of Stanford School of Medicine in 2012. Matthew's passion for addressing unmet medical needs in preeclampsia is a direct result of almost losing his wife during the birth of his son to this horrible syndrome. Matthew has over 15 years experience in biomarker and drug development across all stages of development. He started his career at Biogen Idec and was subsequently recruited to Roche, where he ultimately assumed the role of Global Head of Non-clinical Safety Information. Matthew has also served in leadership roles in miscellaneous industry consortia, including the Chair of the Data Analysis and Management Working Group for the Predictive Safety Testing Consortium (PSTC) at the Critical Path Institute. He recently earned dual MBAs from Columbia Business School and the Berkeley Haas School of Business. He is board certified in toxicology (Diplomat of the American Board of Toxicology) and has earned a Certificate of Entrepreneurship from the Berkeley Haas School of Business. Matthew advises start-ups in the healthcare and healthcare IT spaces and is currently a mentor for the Business Association of Stanford Entrepreneurial Students, Berkeley Haas School of Business, and UCSF Lean LaunchPad for the Life Sciences. He joined the Board in 2014.

John D. Jacobson, MD, became a supporter of the Foundation while seeking an understanding of preeclampsia after the mother of his granddaughter died of complications of HELLP Syndrome in 2005. Dr. Jacobson received his medical degree from the University of Washington. Before returning to Seattle for his anesthesia residency, he served as a flight surgeon in the United States Air Force with assignments to Viet Nam and England. He recently retired from his anesthesia practice at Eisenhower Memorial Hospital in Rancho Mirage, California. He resides with his wife, Karen, in Palm Desert, CA. They have three sons and five, soon to be six, grandchildren. Dr. Jacobson has served on the Board since 2013.

Linda J. Murray is the Senior Vice President of Editorial and Global Editor in Chief of, the #1 parenting and pregnancy digital resource around the world. She has addressed a variety of parenting topics on national television. Her numerous appearances include: "Dr. Phil";  "Anderson"; "20/20"; NBC-TV's "Today"; CBS-TV's "The Early Show"; "Access Hollywood"; "Extra"; CNN; ABC-TV's  "Good Morning America" and MSNBC. Ms. Murray has represented the voice of American mothers at national summits including a post-State of the Union education roundtable at The White House. And she has written on the state of global Motherhood for The Huffington Post. Linda is co-author of The BabyCenter Essential Guide to Pregnancy and Birth and The BabyCenter Essential Guide to Your Baby's First Year. She is also the editor of two new books, BabyCenter Pregnancy: From Preconception to Birth, and BabyCenter Baby: The All Important First Year (DK Publishing, August 2010). Prior to joining BabyCenter, Linda was a Senior Editor at Child magazine where she specialized in the subjects of children's health and safety. Her career also included editing positions at Redbook, Self, and Cosmopolitan magazines, and a producing role on the public television program, "The Open Mind." A transplanted New Yorker, Linda now lives in the Bay Area with her family where she enjoys horseback riding with her daughter in her free time. Ms. Murray has served on the Board since 2013.

JOIN OUR MAILING LIST. We respect your privacy.